TSW
STIM icon

Thompson Siegel & Walmsley’s Neuronetics STIM Stock Holding History

Thompson Siegel & Walmsley’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-88,702
Closed -$422K – 378
2024
Q1 		$422K Sell
88,702
-99,211
-53% -$349K 0.01% 306
2023
Q4 		$545K Buy
+187,913
New +$296K 0.01% 289
2021
Q4 		– Sell
-5,861
Closed -$38K – 726
2021
Q3 		$38K Hold
5,861
– – ﹤0.01% 508
2021
Q2 		$94K Hold
5,861
– – ﹤0.01% 435
2021
Q1 		$73K Buy
+5,861
New +$89.8K ﹤0.01% 440

Other funds holding STIM

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Thompson Siegel & Walmsley's STIM Position: Q2 2024 in Review

Thompson Siegel & Walmsley sold out of Neuronetics (STIM) in Q2 2024, closing a stake of 88,702 shares — an estimated $422K sold.

Thompson Siegel & Walmsley first reported a position in STIM in Q1 2021 and held it in 5 quarters. The position peaked at $545K in Q4 2023. 67 funds tracked by Wall St. Rank hold STIM as of Q2 2024.

  • Thompson Siegel & Walmsley reported no remaining Neuronetics position as of Q2 2024 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 88,702 Neuronetics shares in Q2 2024, an estimated $422K.
  • Thompson Siegel & Walmsley first reported a position in Neuronetics in Q1 2021 and held it in 5 quarters.
  • Thompson Siegel & Walmsley's Neuronetics position peaked at $545K in Q4 2023.
  • 67 funds tracked by Wall St. Rank held Neuronetics as of Q2 2024.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2024, filed 8 Aug 2024.